Oppenheimer & Co’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,944
Closed -$182K 1438
2024
Q1
$182K Sell
12,944
-1,500
-10% -$21.1K ﹤0.01% 1355
2023
Q4
$111K Sell
14,444
-83
-0.6% -$637 ﹤0.01% 1330
2023
Q3
$108K Hold
14,527
﹤0.01% 1316
2023
Q2
$121K Sell
14,527
-1,500
-9% -$12.5K ﹤0.01% 1339
2023
Q1
$213K Buy
16,027
+11
+0.1% +$146 ﹤0.01% 1242
2022
Q4
$238K Sell
16,016
-1,800
-10% -$26.8K 0.01% 1176
2022
Q3
$161K Sell
17,816
-5,800
-25% -$52.4K ﹤0.01% 1252
2022
Q2
$71K Hold
23,616
﹤0.01% 1354
2022
Q1
$158K Buy
23,616
+1,800
+8% +$12K ﹤0.01% 1386
2021
Q4
$118K Buy
21,816
+9,567
+78% +$51.7K ﹤0.01% 1436
2021
Q3
$108K Buy
12,249
+1,999
+20% +$17.6K ﹤0.01% 1446
2021
Q2
$130K Sell
10,250
-917
-8% -$11.6K ﹤0.01% 1457
2021
Q1
$194K Sell
11,167
-533
-5% -$9.26K ﹤0.01% 1354
2020
Q4
$150K Sell
11,700
-5,920
-34% -$75.9K ﹤0.01% 1281
2020
Q3
$654K Sell
17,620
-290
-2% -$10.8K 0.02% 723
2020
Q2
$691K Sell
17,910
-120
-0.7% -$4.63K 0.02% 690
2020
Q1
$449K Buy
18,030
+4,988
+38% +$124K 0.01% 771
2019
Q4
$462K Sell
13,042
-266
-2% -$9.42K 0.01% 864
2019
Q3
$431K Buy
13,308
+1,857
+16% +$60.1K 0.01% 844
2019
Q2
$554K Sell
11,451
-3,863
-25% -$187K 0.02% 768
2019
Q1
$727K Buy
15,314
+7,550
+97% +$358K 0.02% 683
2018
Q4
$203K Sell
7,764
-710
-8% -$18.6K 0.01% 1097
2018
Q3
$407K Buy
8,474
+5,174
+157% +$249K 0.01% 942
2018
Q2
$190K Buy
3,300
+400
+14% +$23K 0.01% 1229
2018
Q1
$315K Hold
2,900
0.01% 1034
2017
Q4
$259K Buy
2,900
+83
+3% +$7.41K 0.01% 1117
2017
Q3
$358K Buy
2,817
+817
+41% +$104K 0.01% 966
2017
Q2
$169K Buy
2,000
+500
+33% +$42.3K ﹤0.01% 1212
2017
Q1
$144K Buy
+1,500
New +$144K ﹤0.01% 1221